O'Shaunessy Ventures Funds Chronic Pain Classification Research
Event summary
- O'Shaunessy Ventures awarded a $100,000 fellowship to Alex Araki for chronic pain classification research.
- Araki aims to develop a non-invasive diagnostic test distinguishing chronic pain types using brain imaging and blood/saliva analysis.
- The 12-month project seeks to create a prototype for fast, low-cost chronic pain diagnosis.
- Araki is a chronic pain patient with a decade of research in aging-related diseases.
The big picture
O'Shaunessy Ventures' investment in chronic pain classification aligns with broader trends toward precision medicine, where diagnostic tools enable targeted treatments. The fellowship program reflects the firm's strategy of backing high-impact research at early stages. Chronic pain affects hundreds of millions globally, representing a massive unmet medical need.
What we're watching
- Prototype Development
- Whether Araki can deliver a functional prototype within the 12-month timeline.
- Diagnostic Validation
- The pace at which the diagnostic test achieves clinical validation and regulatory approval.
- Market Potential
- How this research could transform chronic pain treatment from a one-size-fits-all approach to personalized medicine.
Related topics